SSA
CLVS
Schonfeld Strategic Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-10,300
| Closed | -$28K | – | 2952 |
|
|
2021
Q4 | $28K | Buy |
+10,300
| New | +$28K | ﹤0.01% | 1894 |
|
|
2021
Q2 | – | Sell |
-25,807
| Closed | -$181K | – | 2407 |
|
|
2021
Q1 | $181K | Buy |
+25,807
| New | +$181K | ﹤0.01% | 1499 |
|
|
2020
Q4 | – | Sell |
-267,646
| Closed | -$1.56M | – | 1914 |
|
|
2020
Q3 | $1.56M | Buy |
+267,646
| New | +$1.56M | 0.03% | 549 |
|
|
2020
Q2 | – | Sell |
-14,585
| Closed | -$93K | – | 1592 |
|
|
2020
Q1 | $93K | Buy |
+14,585
| New | +$93K | 0.01% | 1011 |
|
|
2018
Q1 | – | Sell |
-69,240
| Closed | -$4.71M | – | 1009 |
|
|
2017
Q4 | $4.71M | Buy |
69,240
+23,176
| +50% | +$1.58M | 0.39% | 75 |
|
|
2017
Q3 | $3.8M | Sell |
46,064
-64,593
| -58% | -$5.32M | 0.35% | 93 |
|
|
2017
Q2 | $10.4M | Buy |
110,657
+65,939
| +147% | +$6.17M | 1.07% | 9 |
|
|
2017
Q1 | $2.85M | Buy |
44,718
+7,844
| +21% | +$499K | 0.29% | 104 |
|
|
2016
Q4 | $1.64M | Sell |
36,874
-109,448
| -75% | -$4.86M | 0.21% | 139 |
|
|
2016
Q3 | $5.28M | Buy |
146,322
+121,882
| +499% | +$4.39M | 0.9% | 25 |
|
|
2016
Q2 | $336K | Buy |
24,440
+12,344
| +102% | +$170K | 0.08% | 291 |
|
|
2016
Q1 | $233K | Buy |
+12,096
| New | +$233K | 0.1% | 256 |
|